A detailed history of Greenleaf Trust transactions in Boston Scientific Corp stock. As of the latest transaction made, Greenleaf Trust holds 25,302 shares of BSX stock, worth $2.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
25,302
Previous 25,483 0.71%
Holding current value
$2.4 Million
Previous $1.96 Million 8.05%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$72.96 - $84.0 $13,205 - $15,204
-181 Reduced 0.71%
25,302 $2.12 Million
Q2 2024

Jul 22, 2024

BUY
$67.33 - $77.71 $63,559 - $73,358
944 Added 3.85%
25,483 $1.96 Million
Q1 2024

Apr 29, 2024

SELL
$57.6 - $68.62 $11,232 - $13,380
-195 Reduced 0.79%
24,539 $1.68 Million
Q4 2023

Jan 31, 2024

BUY
$48.64 - $57.81 $106,862 - $127,008
2,197 Added 9.75%
24,734 $1.43 Million
Q3 2023

Nov 09, 2023

BUY
$50.19 - $54.68 $24,844 - $27,066
495 Added 2.25%
22,537 $1.19 Million
Q2 2023

Aug 09, 2023

SELL
$49.72 - $54.64 $58,669 - $64,475
-1,180 Reduced 5.08%
22,042 $1.19 Million
Q1 2023

May 11, 2023

BUY
$45.09 - $50.03 $85,220 - $94,556
1,890 Added 8.86%
23,222 $1.16 Million
Q4 2022

Jan 25, 2023

BUY
$39.56 - $47.22 $89,445 - $106,764
2,261 Added 11.86%
21,332 $987,000
Q3 2022

Nov 10, 2022

BUY
$36.71 - $109.66 $85,020 - $253,972
2,316 Added 13.82%
19,071 $739,000
Q2 2022

Aug 12, 2022

SELL
$35.24 - $47.1 $45,600 - $60,947
-1,294 Reduced 7.17%
16,755 $624,000
Q1 2022

Apr 27, 2022

BUY
$40.9 - $45.1 $72,393 - $79,827
1,770 Added 10.87%
18,049 $799,000
Q4 2021

Feb 11, 2022

BUY
$38.07 - $44.87 $60,302 - $71,074
1,584 Added 10.78%
16,279 $692,000
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $50,053 - $55,698
1,214 Added 9.01%
14,695 $638,000
Q2 2021

Aug 10, 2021

BUY
$38.58 - $44.24 $25,038 - $28,711
649 Added 5.06%
13,481 $576,000
Q1 2021

Apr 30, 2021

BUY
$35.27 - $39.67 $138,575 - $155,863
3,929 Added 44.13%
12,832 $496,000
Q4 2020

Feb 08, 2021

SELL
$33.15 - $41.97 $78,101 - $98,881
-2,356 Reduced 20.93%
8,903 $320,000
Q3 2020

Oct 30, 2020

BUY
$34.44 - $42.23 $75,940 - $93,117
2,205 Added 24.35%
11,259 $430,000
Q2 2020

Aug 12, 2020

BUY
$30.19 - $39.11 $25,540 - $33,087
846 Added 10.31%
9,054 $318,000
Q1 2020

Apr 29, 2020

SELL
$25.83 - $45.71 $65,789 - $116,423
-2,547 Reduced 23.68%
8,208 $268,000
Q4 2019

Feb 11, 2020

SELL
$37.87 - $45.37 $4,733 - $5,671
-125 Reduced 1.15%
10,755 $486,000
Q3 2019

Nov 08, 2019

BUY
$40.31 - $43.45 $22,573 - $24,332
560 Added 5.43%
10,880 $443,000
Q2 2019

Jul 24, 2019

BUY
$34.91 - $42.98 $17,524 - $21,575
502 Added 5.11%
10,320 $444,000
Q1 2019

May 08, 2019

BUY
$32.91 - $40.75 $24,123 - $29,869
733 Added 8.07%
9,818 $377,000
Q4 2018

Feb 07, 2019

BUY
$31.73 - $39.04 $33,538 - $41,265
1,057 Added 13.17%
9,085 $321,000
Q3 2018

Oct 29, 2018

BUY
$32.83 - $38.63 $263,559 - $310,121
8,028 New
8,028 $309,000
Q1 2018

Apr 30, 2018

SELL
$25.2 - $28.54 $9,878 - $11,187
-392 Closed
0 $0
Q4 2017

Feb 08, 2018

SELL
$24.79 - $29.8 $1,313 - $1,579
-53 Reduced 11.91%
392 $10,000
Q3 2017

Nov 13, 2017

BUY
$26.26 - $29.17 $11,685 - $12,980
445
445 $13,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $136B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Greenleaf Trust Portfolio

Follow Greenleaf Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.